Journal of Clinical Epidemiology

Article	Citations
GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies	1628
Screening colonoscopy similarly prevented distal and proximal colorectal cancer: a prospective study among 55–69-year-olds	1488
Interrater reliability of ROB2 – an alternative measure and way of categorization	216
A review identified challenges distinguishing primary reports of randomized trials for meta-research: A proposal for improved reporting	194
Antidepressant prescriptions have not fully reflected evolving evidence from cumulative network meta-analyses and guideline recommendations	174
A general explanation of the counterfactual definition of confounding	162
Recording harms in randomized controlled trials of behavior change interventions: a scoping review and map of the evidence	152
Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort	143
Multimorbidity, activity limitation and self-reported health all predict mortality risk, but better measures were required	137
Corrigendum to ‘Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches’ [Journal of Clinical Epidemiolog	137
Design, methods, and reporting of impact studies of cardiovascular clinical prediction rules are suboptimal: a systematic review	130
Types and associated methodologies of overviews of reviews in health care: a methodological study with published examples	128
Visualizing the value of diagnostic tests and prediction models, part III. Numerical example with discrete risk groups and miscalibration	96
Measuring the environmental impact of health interventions in randomised controlled trials – a scoping review	95
More than two-dozen prescription drug-based risk scores are available for risk adjustment: A systematic review	94
Randomized COVID-19 vaccination rollout can offer direct real-world evidence	91
The construct of certainty of evidence has not been disseminated to systematic reviews and clinical practice guidelines; response to ‘The GRADE Working Group’ et al	84
Many thanks to our reviewers	84
Reporting of funding and conflicts of interest improved from preprints to peer-reviewed publications of biomedical research	82
Editorial Board	82
Empirical evaluation of the methods used in systematic reviews including observational studies and randomized trials	82
Editorial Board	79
The inclusion of outcomes in search strategies for Cochrane Reviews: authors’ reply	78
Two-decade health-related quality of life and performance on physical function tests in midaged women: findings from a prospective cohort study	74
Results reporting for clinical trials led by medical universities and university hospitals in the nordic countries was often missing or delayed	72

Psychometric evaluation of a new drug-resistant tuberculosis stigma scale	71
Potential interactions between digoxin and direct oral anticoagulants: application of cohort & novel case-crossover designs	71
Double-zero-event studies matter: A re-evaluation of physical distancing, face masks, and eye protection for preventing person-to-person transmission of COVID-19 and its policy impact	71
Statistical robustness of randomized controlled trials in high-impact journals has improved but was low across medical specialties	70
Strong and high-quality evidence synthesis needs Cochrane: a statement of support by the GRADE Guidance Group	70
Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin	69
Pharmacovigilance studies without a priori hypothesis: systematic review highlights inappropriate multiple testing correction procedures	65
Harms were detected but not reported in six clinical trials of gabapentin	64
Meta-analysis of individual participant data and informed consent: a small step, but important and neglected	64
A Bayesian-adaptive decision-theoretic approach can reduce the sample sizes for multiarm exercise oncology trials	61
External validation of six COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home setting	59
Allocation of scarce resources in a pandemic: rapid systematic review update of strategies for policymakers	59
JBI series paper 2: tailored evidence synthesis approaches are required to answer diverse questions: a pragmatic evidence synthesis toolkit from JBI	58
Librarian involvement in systematic reviews was associated with higher quality of reported search methods: a cross-sectional survey	58
GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses	56
Advances in methodologies of negative controls: a scoping review	56
Handling missing data in clinical research	54
RETRACTED: Part II: a step-by-step guide to latent class analysis	54
A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes	54
External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb	54
The walking man approach to interpreting the receiver operating characteristic curve and area under the receiver operating characteristic curve	53
Searching two or more databases decreased the risk of missing relevant studies: a metaresearch study	52
Methodological quality assessment tools for diagnosis and prognosis research: overview and guidance	50
The use of GRADE approach in Cochrane reviews of TCM was insufficient: a cross-sectional survey	48
Controversy and debate: challenges with the need to improve the reference standard in diagnosis paper 1: two challenges: absence of a clear cut, easily replicable test for the reference standard; unet	48
Meta-analysis of multi-jurisdictional health administrative data from distributed networks approximated individual-level multivariable regression	47
Editorial Board	46
Many systematic reviews with a single author are indexed in PubMed	45
Reconciling contrasting guideline recommendations on red and processed meat for health outcomes	45
Methodological quality was critically low in 9/10 systematic reviews in advanced cancer patients—A methodological study	44
Abstracts for reports of randomized trials of COVID-19 interventions had low quality and high spin	43
Indirectness (transferability) is critical when considering existing economic evaluations for GRADE clinical practice guidelines: a systematic review	42
The performance of three nutritional tools varied in colorectal cancer patients: a retrospective analysis	41
Item response theory may account for unequal item weighting and individual-level measurement error in trials that use PROMs: a psychometric sensitivity analysis of the TOPKAT trial	40
Table of Contents	39
Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer	39
The World Conference on Research Integrity 2024	38
Editors’ Choice: October 2024	38
Promoting responsible scientific research: integrating retractions into the ORCID profile	38
Editors' Choice September 2024	37
Improving grading of recommendations assessment, development, and evaluation evidence tables part 4: a three-arm noninferiority randomized trial demonstrates improved understanding of content in summa	37
Heterogeneity across outcomes reported in clinical trials for older adults with depression: a systematic survey	36
A few things to consider when deciding whether or not to conduct underpowered research	35
Table of Contents	35
Sample size considerations are needed for the causal analyses of existing databases	35
Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials	34
Response to “Homeopathy: A null field or effective psychotherapy?”	34
Prevalence of and factors associated with potentially redundant randomized controlled trials: a cross-sectional study	34
Improved reporting of selection processes in clinical database research: author's reply	34
A method was developed for correcting the bias in the usual study weights in meta-analyses	34

A multimethods randomized trial found that plain language versions improved parents’ understanding of health recommendations	34
Is it time for a common peer review format for biomedical journals?	34
Incorporating postmenopausal women's perspectives into osteoporosis clinical guidelines: a systematic review	34
Defining decision thresholds for judgments on health benefits and harms using the grading of recommendations assessment, development, and evaluation (GRADE) evidence to decision (EtD) frameworks: a ra	33
Editors' Choice - July 2023	33
Machine learning reduced workload with minimal risk of missing studies: development and evaluation of a randomized controlled trial classifier for Cochrane Reviews	33
Editors' Choice: February 2022	33
Methodology over metrics: Response to Van Calster et al	32
Intent to share Annals of Internal Medicine's trial data was not associated with data re-use	32
Including nonrandomized studies of interventions in systematic reviews: principles and practicalities	31
Accounting for differential exclusions in the Nordic-European initiative on colorectal cancer trial discloses stronger-than-reported effects of screening colonoscopy	31
Assessing the scientific integrity of the collected work of one author or author group	31
A review found small variable blocking schemes may not protect against selection bias in randomized controlled trials	30
Sample sizes of prediction model studies in prostate cancer were rarely justified and often insufficient	30
A framework for evaluating predictive models	29
Methods for living guidelines: early guidance based on practical experience. Paper 5: decisions on methods for evidence synthesis and recommendation development for living guidelines	29
A few panel members dominated guideline development meeting discussions: Social network analysis	29
A new taxonomy is proposed for defining the interests of stakeholders’ representatives in health research: the case of guideline development	29
Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score	28
AMSTAR 2 is only partially applicable to systematic reviews of non-intervention studies: a meta-research study	28
Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty	28
Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases	28
Research misconduct tests: putting patients’ interests first	27
Validation of the Persistent Somatic Symptom Stigma Scale for Healthcare Professionals	27
Data-driven methods distort optimal cutoffs and accuracy estimates of depression screening tools: a simulation study using individual participant data	27
BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals	27
Systematic review of multivariable prognostic models for outcomes at least 30 days after hip fracture finds 18 mortality models but no nonmortality models warranting validation	27
A prospective comparison of evidence synthesis search strategies developed with and without text-mining tools	27
Epidemiology and development economics two sides of the same coin in impact evaluation	26
Editors’ Choice January 2025	26
Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional study	26
Characteristics and completeness of reporting of systematic reviews of prevalence studies in adult populations: a metaresearch study	26
Use of participant data and biological samples is insufficiently described in participant information leaflets	26
Author queries via email text elicited high response and took less reviewer time than data forms – a randomised study within a review	26
Will COVID-19 result in a giant step backwards for women in academic science?	26
The impact of climate change on health needs structured evidence assessment and an evidence to action framework to make decisions: a proposal to adopt the GRADE approach	26
Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice	25
GRADE guidance 36: updates to GRADE's approach to addressing inconsistency	25
Qualitative study of guideline panelists: innovative surveys provided valuable insights regarding patient values and preferences	25
Surrogate endpoint metaregression: useful statistics for regulators and trialists	25
Part I: A friendly introduction to latent class analysis	25
Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction	24
In a pilot study, automated real-time systematic review updates were feasible, accurate, and work-saving	24
Why clinical context and relevant protocols matter: author's reply	24
Missing data is poorly handled and reported in prediction model studies using machine learning: a literature review	24
Psychometric properties and domains covered by patient-reported outcome measures used in trials assessing interventions for chronic pain	24
Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping	24
New research questions identified for Cochrane reviews: a cross-sectional study of a specialized register: part two: fertility	23
Table of Contents	23
Flexible approaches to clinical trials	23
Letter to the Editor - Methodological quality was critically low in 9/10 systematic reviews in advanced cancer patients—A methodological study	23
13-Year colorectal cancer risk after lower-quality, higher-quality and no screening colonoscopy: a cohort study	23
Toward an observatory of the evolution of clinical trials through phylomemy reconstruction: the COVID-19 vaccines example	23
Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesis	22
Letter to the editor regarding "Incomparability of treatment groups is often blindly ignored in randomised controlled trials – a post hoc analysis of baseline characteristic tables"	22
Generative artificial intelligence and academic writing: friend or foe?	22
Response to Weinfurt and Cappelleri on “Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses sho	22
Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment	21
Gynecological trials frequently exclude people based on their symptoms rather than their condition: a systematic review of Cochrane reviews and their component trials	21
The Net Benefit of a treatment should take the correlation between benefits and harms into account	21
Answers to comments by Jonas Schmidt, Casper Urth Pedersen, and Sisse Helle Njor	21
Mapping intersectional sociodemographic inequalities in measurement and prevalence of depressive symptoms: a intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy	21
Temporal improvements noted in life expectancy of patients with colorectal cancer; a Dutch population-based study	21
Underserved groups remain underserved as eligibility criteria routinely exclude them from breast cancer trials	21
Informed consent for national registration of COVID-19 vaccination caused information bias of vaccine effectiveness estimates mostly in older adults: a bias correction study	21
A structured methodology review showed analyses of functional outcomes are frequently limited to “survivors only” in trials enrolling patients at high risk of death	21
Prevalence of patient partner authorship and acknowledgment in child health research publications: an umbrella review	21
No short-term mortality from benzodiazepine use post-acute ischemic stroke after accounting for bias	21
Implementation of a dynamic model updating pipeline provides a systematic process for maintaining performance of prediction models	21
Patient-reported outcomes and measures are under-utilised in advanced therapy medicinal products trials for orphan conditions	21
Let's end “real-world evidence” terminology usage: A study should be identified by its design	20
Author’s reply: “The importance of properly specifying your target trial emulation: commentary on Mésidor et al.”	20
Pain and physical function are common core domains across 40 core outcome sets of musculoskeletal conditions: a systematic review	20
The role of scoping reviews in guideline development	20
Editorial, April 2025	20
Validation and impact of algorithms for identifying variables in observational studies of routinely collected data	19
Why trials lose participants: A multitrial investigation of participants’ perspectives using the theoretical domains framework	19
Joint modeling of endpoints can be used to answer various research questions in randomized clinical trials	19
Decision-making given surrogate outcomes	19
The Odds Ratio is “portable” across baseline risk but not the Relative Risk: Time to do away with the log link in binomial regression	19

Reporting of health equity considerations in vaccine trials for COVID-19: a methodological review	18
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration	18
Guidelines that use the GRADE approach often fail to provide complete economic information for recommendations: A systematic survey	18
Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies	18
A scoping review of the assessment reports of genetic or genomic tests reveals inconsistent consideration of key dimensions of clinical utility	18
Tutorial on directed acyclic graphs	18
Meta-epidemiological study of publication integrity, and quality of conduct and reporting of randomized trials included in a systematic review of low back pain	18
Meta-analysis for individual participant data with a continuous exposure: A case study	18
Weekly updating of guideline recommendations was feasible: the Australian National COVID-19 clinical evidence Taskforce	17
Table of Contents	17
The influence of the dynamic context of the pandemic on the predictive performance of mortality predictions over time in older patients hospitalized for COVID-19	17
2,109 randomized oncology trials map continuous, meager improvements in progression-free and overall survival over 50 years	17
Challenges with need to improve the reference standard in diagnosis: paper 2: real-world case examples from GRADE for when a reference standard is not clearly defined/ easily replicable or when it is	17
There is a need to address uptake of core outcome sets in research and guidelines	17
Response rates in email vs. mail surveys for urologists: a randomized controlled trial	17
Inclusion of harm outcomes in core outcome sets requires careful consideration	17
Table of Contents	17
Resource use during systematic review production varies widely: a scoping review: response to Nussbaumer-Streit et al.	17
Strength of statistical evidence for the efficacy of cancer drugs: a Bayesian reanalysis of randomized trials supporting Food and Drug Administration approval	17
Editorial Board	17
Table of Contents	17
Table of Contents	17
The methods adopted by Autier et al do not support their conclusions	16
Associations of hypothetical early intensive in-hospital rehabilitation with activities of daily living after hip fracture surgery in patients with and without dementia: emulating a randomized control	16
Considerations for the use of biochemical laboratory registry data in clinical and public health research	16
Improving the analysis of adverse event data in randomized controlled trials	16
Rasch analysis highlighted relative importance of walking and transferring disabilities among elderly in developing countries	16
A classification of methods used to personalize participative interventions revealed inadequate reporting in trial protocols	16
Editorial Board	16
Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness & safety	16
Assessment of Standards for Reporting of Diagnostic Accuracy (STARD) 2015 guideline adherence in medical imaging diagnostic accuracy studies published in 2023	16
A multifaceted graphical display, including treatment ranking, was developed to aid interpretation of network meta-analysis	16
Methodological systematic review recommends improvements to conduct and reporting when meta-analyzing interrupted time series studies	16
A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map	16
Development of a refined harmonization approach for longitudinal cognitive data in people with HIV	16
Comments, suggestions, and criticisms of the Pragmatic Explanatory Continuum Indicator Summary-2 design tool: a citation analysis	16
Exploring the use and usefulness of living guidelines for consumers: international online survey of patients' and carers' views	16
Sponsorship bias in oncology cost effectiveness analysis	16
No inexplicable disagreements between real-world data–based nonrandomized controlled studies and randomized controlled trials were found	16
Comparative effectiveness research considered methodological insights from simulation studies in physician's prescribing preference	15
Presentation approaches for enhancing interpretability of patient-reported outcomes in meta-analyses: a systematic survey of Cochrane reviews	15
Differentiating between mapping reviews and evidence gap maps	15
Editorial Board	15
The value of international collaboration	15
GRADE Guidance: 31. Assessing the certainty across a body of evidence for comparative test accuracy	15
David Sackett Young Investigator Award 2021	15
Editors’ Choice: October 2021	15
Most systematic reviews that used the term “update” in title/abstract were not an updated version	15
Evidence Based Social Science in China Paper 4 : The quality of social science systematic reviews and meta-analysis published from 2000-2019	15
Present state bias in transition ratings was accurately estimated in simulated and real data	15
Why methods matter in a meta-analysis: a reappraisal showed inconclusive injury preventive effect of Nordic hamstring exercise	15
Estimates of sensitivity and specificity of serological tests for SARS-CoV-2 specific antibodies using a Bayesian latent class model approach	14
Domperidone increases harmful cardiac events in Parkinson's disease: A Bayesian re-analysis of an observational study	14
Researcher-patient partnership generated actionable recommendations, using quantitative evaluation and deliberative dialogue, to improve meaningful engagement	14
A review of health equity considerations in Cochrane reviews of lifestyle interventions for cardiovascular health in adults	14
Persistent ethnic disparities in authorship within top European and North American medical journals: a serial cross-sectional analysis	14
Funding matters: time to update preferred reporting items for systematic reviews and meta-analyses?	14
Editors’ Choice May 2022: Evidence-Based-Research, Surrogate Outcomes and Exclusion of Old Systematic Reviews in Meta-analyses	14
Meta-research studies should improve and evaluate their own data sharing practices	14
Individual patient data meta-analysis estimates the minimal detectable change of the Geriatric Depression Scale-15	14
Data quality assessment of interventional trials in public trial databases	14
Critical elements of synthesis questions are incompletely reported: survey of systematic reviews of intervention effects	14
Paper 2: themes from semistructured interviews	14
Empirical studies of balance do not justify a requirement for 1,000 patients per trial	14
PRIME-IPD SERIES Part 3. The PRIME-IPD tool fills a gap in guidance for preparing IPD for analysis	14
PRIME-IPD SERIES Part 1. The PRIME-IPD tool promoted verification and standardization of study datasets retrieved for IPD meta-analysis	14
Geriatric impairments were directly and indirectly associated with mortality in older patients with cancer: a structural equation analysis	14
“How-to”: scoping review?	14
The fragility index can be used for sample size calculations in clinical trials	13
“Evidence-based checklists” for identifying predatory journals have not been assessed for reliability or validity: An analysis and proposal for moving forward	13
Minimal important change was on the lower spectrum of previous estimates and responsiveness was sufficient for core outcomes in chronic low back pain	13
The use of the E-value for sensitivity analysis	13
Logistic regression and machine learning predicted patient mortality from large sets of diagnosis codes comparably	13
Methodological approaches for developing, reporting, and assessing evidence-based clinical practice guidelines: a systematic survey	13
Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study	13
Open science failed to penetrate academic hiring practices: a cross-sectional study	13
Systematic Review Reveals Lack of Causal Methodology Applied to Pooled Longitudinal Observational Infectious Disease Studies	13
Retracted randomized controlled trials were cited and not corrected in systematic reviews and clinical practice guidelines	13
Methods for living guidelines: early guidance based on practical experience. Paper 3: selecting and prioritizing questions for living guidelines	13
Sankey diagrams can clarify ‘evidence attrition’: A systematic review and meta-analysis of the effectiveness of rapid diagnostic tests for antimicrobial resistance	13
Increased endorsement of TRIPOD and other reporting guidelines by high impact factor journals: survey of instructions to authors	13
Variation observed in consensus judgments between pairs of reviewers when assessing the risk of bias due to missing evidence in a sample of published meta-analyses of nutrition research	13
Substantial heterogeneity found in reporting mortality in Cochrane systematic reviews and Core Outcome Sets in COMET database	13
We extended the 2-week systematic review (2weekSR) methodology to larger, more complex systematic reviews: A case series	13
High certainty evidence is stable and trustworthy, whereas evidence of moderate or lower certainty may be equally prone to being unstable	13
Interrupted time-series analysis showed unintended consequences of non-pharmaceutical interventions on pediatric hospital admissions	13
Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study	13
Do not make clinical decisions based on abstracts of healthcare research: A systematic review	13
Paper 4: a systematic review on the use of logic models and frameworks for methodological conduct of evidence synthesis	13
Large variation existed in standardized mean difference estimates using different calculation methods in clinical trials	13
Beyond statistical significance: nuanced interpretations of statistically nonsignificant results were rare in Cochrane reviews – a metaepidemiological study	13
Assessing conflict of interest reporting and quality of clinical trials on infant formula: a systematic review	12
Applying calculations to clinical medicine requires nuance: response to Uy	12
Reporting transparency and completeness in trials: Paper 3 – trials conducted using administrative databases do not adequately report elements related to use of databases	12
Quality of surgical patient-reported outcome measure validation studies is often deficient: a systematic review	12